Psoriasis is a common skin disease in which retinoids have be neficial effects. It offers a model for th e study of benign hyperproliferation with abno rmal differentiation. The derm is h as a prominent rol e in the appearance of epidermal lesio ns. It is th erefo re of interest to study the factors that m odulate dermal ce ll proliferation. In this study, the role of retinoids in modulating pl atelet-derived growth factor (PDGF) bioactivity was studied in normal (six subjects) and psoriatic fibrobl as ts from involved and uninvolved tissues (s ix patients).
Psoriasis is a common skin disease in which retinoids have be neficial effects. It offers a model for th e study of benign hyperproliferation with abno rmal differentiation. The derm is h as a prominent rol e in the appearance of epidermal lesio ns. It is th erefo re of interest to study the factors that m odulate dermal ce ll proliferation. In this study, the role of retinoids in modulating pl atelet-derived growth factor (PDGF) bioactivity was studied in normal (six subjects) and psoriatic fibrobl as ts from involved and uninvolved tissues (s ix patients).
R etinoic acid treatment (for 4 d at 10-6 M) of psoriatic fi broblasts si g nificantl y increased the chemotactic effect of P DGF in these cells (p < 0.01 and p < 0 .05, respectively, in involved and uninvolved skin at 20 ng/ ml of platelet-P sori as is is a common skin disease in wh ich retinoids have benefi cial effects. Psoriasis provides a model for th e study of beni gn hyperproliferation with abnormal differentiation. Psoriasis is thought to be principall y a disease of the epidermis that causes a disruption in the norma l events of keratinocyte maturation and proliferation [1 ,2) . Recent studies [3, 4) offer evidence that th e dermis has a prominent ro le in the appearance of psoriatic lesions; psoriatic fibrobl asts ind uce th e hyperprolife ration of normal keratinocytes in vitro, suggesting that the primary defect in psoriatic skin may reside in dermal fib robl as ts. It is th erefore of interest to study the growth properties of psoriatic fib roblasts in culture, as well as th e fac tors that modulate these growth properti es .
W e have previously shown that psoriatic, as compared to normal, fib robl as ts have increased sensitivity to platelet-derived growth factor (PDGF) [5) . PD GF is a heat-stabl e basic protein, highly mitogenic fo r fibrobl as ts wh en added to plasma [6 ,7) and is one of th e major chemotactic age nts for th ese cells [8) . PDGF derived from human pl atelets is a disulfide-linked heterodimer consistin g of an A M anuscript rece ived D ecember 19, 1989 ; accepted fo r publication Jul y 19 , 1990 .
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Rep derived growth factor as m easured in a modified Boyden Chamber Assay). In the same way , retinoic acid treatment of psoriatic fibroblasts increased the mitogenicity of plateletderived growth factor in these cells. Retinoic acid treatment has no significant effect on the mito genic and chemotactic activity of PDGF in normal fibroblasts. Th e binding of the homodimer BB PDGF to its type-B receptor, which mediates the mitogenic and chemotactic effect of PDGF, was not modified by retinoic acid treatment either in psoriatic and/or normal fibroblasts.
These results suggest that retinoic acid may modulate the PDGF bioactivity in psoriatic fibroblasts not by affecting the binding of this ligand to these cells but by influencing a post-receptor event. J Invest Dermatol 96: 111 -115, 1991 and B chain, although there is evidence for the presence of homodimers (AA or BB) from other cell sources (see [9) for review). PDGF exerts its biologic activity via binding to specific cell-surface receptors [10) . Two classes of receptors have recently been described, type A and type B [7 -12) .The type-B receptor is identical to the previously identified and cloned PDGF receptor with protein tyrosine kinase activity and mediates the mitogenic and chemotactic effect ofFDGF [11) .
In this study, we demonstrate that retinoic acid increases the chemotactic and mitoge nic effect of PDGF in psoriatic fibroblasts without significantly modifying th e type-B PDGF receptor number or affinity.
MATERIALS AND METHODS
Reagents Highly purified PDGF was purchased from Collaborative Research (Lexington , MA) and was also generously supplied by Dr. G Grotendorst (Charleston, SC). Dulbecco's modified Eagle's medium (DMEM), glutamine, and trypsin were from Flow Laboratories (Puteaux, France); fetal calf serum (FCS) was purchased from Intermed (Strasbourg, France). Nucleopore filters were from Nucleopore Corporation (Pleasanton , CA). Diff-Quik stain was obtained from Merz + Dade AG (Di.idingen, Switzerland). (3H) thymidine (5 cunes/ mmol) .was from Amersham (Les Ulis, Fra nce).
All -trans-v1tamm A (retmo1c ac1d) was ge nerous gift from Hoffmann La Roche.
Cells Human fibrobl as ts were isolated from normal adult and untreated adult .patients by enzymatic digestion of smal l pieces (4 mm) of skm bwps1es taken from non-l esional and lesional tissues.
Bi~psy of the non-lesional tissue was taken about 5 em away from a leswnal area. Th e sbn fragments were rinsed twice with 5 ml of warm DMEM containing penicillin (50 U/ ml) and streptomycin (50 U / ml) . The washed skin sampl es were minced into small pieces 
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and incubated with trypsin (2.5 mg/ml) in 10 ml of DMEM for 1 h. The trypsinized skin fragments were recovered by low-speed centrifugation (1000 rpm for 3 min) and incubated in DMEM containing collagenase (1 mg/ml) for 1 h, followed by incubation in 0.5 mg/ml col lagenase for 18 h at 37°C with shaking in a rotatory incubator (New Brunswick). Cells were pelleted by centrifugation at 400 X g for 10 min, then resuspended in 9 m l of DMEM containing 10% FCS, penicillin (50 U /ml), and streptomycin (50 U / ml), and plated onto a 90-mm cell-culture dish. Cells were grown in a 5% C0 2 -humidified atmosphere at 3 7 o C and culture medium was changed every 3d. At confluence (2.5 106 cells/10-mm dish), cell s were removed by trypsin treatment (0.5% trypsin and 0.2% EDTA) and 7 X 10 5 cells were seeded per dish. The cel ls were used after their third to sixth passage always at the same density (subconfluent).
Chemotaxis Assay As previously described [13] [14] [15] , fibroblasts harvested from culture dishes by brief exposure to a solution of 0.05% trypsin/0 .02% EDT A were suspended in an equal volume of DMEM plus 10% fetal calf serum centrifuged at 1000 rpm for 5 min, and resuspended in the same medium at room temperature for 1 h with occasional agitation. The cells were then washed twice with serum-free DMEM, and suspended in the same medium at a concentration of 1.5 X 10 6 cell s/mi.
Blind-well modified Boyden chemotaxis chamber and Nucleopore polycarbonate filters (8,u-diameter pores) were used to measure fibroblast chemotaxis. The fi lters were treated with 1% gelatin as previously described to promote fibroblast adherence to their upper and lower surfaces (1 3] . One hundred fifteen microliters of various concentrations ofPDGF diluted in DMEM was placed in the lower chamber as attractant. The upper chamber compartments were loaded with 200 ,ul of fibroblast suspension (3 X 10 5 cells). Chemotaxis chambers were incubated at 37°C for 150 min in a humidified atmosphere containing 5% C0 2 • Filters were then removed from the chambers and cells were fixed and stained using Diff-Quik stain (AMS, France). The number of cells on the lower surface of the filter was determined by counting the number of nuclei in 10 fields under a phase-contrast microscope. Chemotaxis assay was performed in duplicate and repeated at least 3 times for each fibroblast culture. Checkerboard analysis showed that PDGF has a specific chemotactic effect and did not increase random motility.
Thymidine Incorporation Mitogenic activity was measured as previously described (16, 17] , with the following modifications. Fibroblasts were plated in 96-wcll micro titer plates at 10 4 cells/well in 0.2 ml DMEM plus 5% FCS with or without retinoic acid 10-6 M. The following day the cells were washed twice with serum-free medium and 0.2 ml serum-free DMEM was added for 48 h to reduce the basal rate of [ 3 H] thymidine incorporation in the presence or absence of lQ-6 M retinoic acid. Aliquots of PDGF at various concentrations were added and the cell s were incubated for 20 h with or without retinoic acid . C ultures were then incubated for 4 h with 0.2 uCi/well (3H] thymidine (5 Ci/mmol) and 5% plateletpoor plasma again with or without retinoic acid. Platelet-poor plasma was prepared as previously described [17) . The cells were harvested by a cell harvester and filterdisc transfer system (SKA-TRON A.B, type 7000) samples from triplicate wells were counted in Beckman LS 3801 Scintillation Countez· using Readysafe (Beckman) as scintill ation fluid. The experiments were repeated twice.
PDGF Binding Assays (3 X 10 4 to 12 X 10 4 ) fibroblasts were plated in 3.5-cm dishes (Costar) and grown for 4 d in the presence or absence of retinoic acid (10-6M) before usc. The binding assay buffer contained DMEM, HEPES (25 mM, pH 7.4) and 0.1% w /v bovine serum albumin (BSA). Cells were incubated with c-sis [ 125 1) PDGF (Amcrsham (1000 Ci/Mmol), 50,000 cpm] in 0.7 ml binding buffer and varying amounts of unlabeled PDGF (from zero to 100 ngjml). Unlabeled PDGF was csis-recombinant PDGF (homodimer BB) from Amersham. Cells were incubated for 2 h at room temperature (21 oq, the binding medium aspirated and dishes washed 5 times with ice-cold phosphate-buffered saline (PBS).
THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
Cell s were solubilized with 2 X i ml of 0.5 M NaOH and extracts counted in a y counter. Normal and psoriatic cells treated or not with retinoic acid were at the · same cell density when used for PDGF binding assays. Non-specific binding (measured in presence of 200 ng/ml of unlabeled PDGF) did not exceed 10% of the total binding.
Retinoic Acid Treatment of Cells Retinoic acid disso lved in absolute ethanol was added to give the indicated concentration, 18 h after cell plating for 4 d. The final concentration of ethanol in the medium (0.01 %) did not alter fibroblasts' growth or PDGF bioactivity (not shown). • Individual values of cutaneous score of the patients and the chemotactic response to 20 ng/ml ofPDGF of the psoriatic and normal fibroblasts cultured 4 din the presence or absence of 10--< M retinoic acid. The number of cells on the lower surface of the filter was determined by countin g the number of nuclei in I 0 fields (0.6 mm in diameter) under a phase-contrast microscope. The results are the mean of at least three experiments and arc expressed as the number of cells on the entire filter ( 45 mm in diameter).
RESULTS

Effect of Retinoic Acid on the Chemotactic Response of Psoriatic Fibroblasts
We previously showed that PDGF is a more potent chemoattractant for psoriatic fibrob lasts compared to normal [5] . a result reproduced here and clearly visible when comparing control curves in the three panels of Fig 1. After 4 d of treatment by retinoic acid at 10-6 M, psoriatic fibroblasts have significantly increased chemotactic response to PDGF compared to untreated psoriatic fibrob lasts (p < 0.01 and p < 0.05, respectively, in involved and uninvolved skin for 20 ng/ml of PDGF) (Fig lB, C ; Table I ). As shown in Fig 2, the effect of retinoic acid on the chemotactic response of psoriatic fibroblasts from uninvolved skin is dose dependent, with a maximal effect observed at 10-7 M of retinoic acid. Similar dose-response effect is observed with psoriatic fibrob lasts from involved skin (data not shown). In contrast, normal fibroblasts treated for 4 d with retinoic acid at l0-6 M have a slight but not significant increase in their chemotactic response to PDGF. None of the doses of retinoic acid tested (Fig.   2 ) has an effect on the PDGF chemotactic activity. Retinoic acid added during the chemotaxis assay has no effect (data not shown).
Effect ofRetinoic Acid on the Mitogenic Response ofPsoriatic Fibroblasts In order to confirm the increased sensitivity of psoriatic fibroblasts to PDGF after retinoic acid treatment, the mitogenic effect of this agent was compared among retinoic acidtreated and untreated psoriatic and normal fibroblasts (Fig 2) .
PDGF in the presence of platelet-poor plasma stimulated the incorporation of (3H) thymidine in a dose-dependent manner in normal and psoriatic fibroblasts (Fig 3) , but PDGF alone in the absence of plasma has no effect either in normal or in psoriatic fibroblasts (data not shown) . After retinoic acid treatment, psoriatic fibroblasts from both involved and uninvolved skin were significantly more sensitive to the mitogenic effect of PDGF than untreated cells (p < 0.01 and p < 0.01, respectively, in involved and uninvolved skin for 20 ng/ml ofPDGF). The dose-response curve of the effect of retinoic acid on the mitogenic response of psoriatic fibroblasts to PDGF is similar to the one observed when the effect of retinoic acid was tested on the chemotactic response (data not shown) . In normal fibrob lasts, retinoic acid had a slight but not significant effect on the mitogenesis induced by PDGF.
Effect of Retinoic Acid on the PDGF Binding to Psoriatic
Fibroblasts To test whether enhancement of PDGF mitogenicity in psoriatic fibroblasts by retinoic acid was due to an alteration in PDGF binding kinetics, we conducted bindin g experiments using (12SI)-labeled C sis PDGF (homodimer BB).
PDGF BB binds specifically on the normal and psoriatic fibroblasts, with a maximal and equilibrium level at 21 o C occurring at 90 min (data not shown). Scatchard plot analysis of the binding data indicate (Fig 4, Table II . Dose-response curve of the effect of retinoic acid on the chemotactic respo nse of psoriatic fibroblasts to PDGF. PDGF at a concentration of 10 ng/ml was added to the lower compartment of a modified Boyden chamber. Fibroblasts from uninvolved skin of two patients were treated for 4 d in the presence of the indicated concentrations of retinoic acid. The chemotaxis assay was performed as described in Materials a11d Methods. Results are expressed as percent of control. The co ntrol represents the migration of fibroblasts cultured in the abse nce of retinoic acid, and tested in rhe presence of 10 ng/ml of PDGF in th e lower compartment of the Boyden chamber. Results are the mean± SEM of triplicate determinations of two experiments in psoriatic fibrobl asts cultured from uninvolved skin of two patients or in fibroblasts cultured from two normal subjects. PDGF ng/ml PSORIATIC (Involved Skin) In the dermis, the functions of fibroblasts are not only to sy nthesize and degrade the extracellul ar matrix but also to regulate epidermalization by remodeling the collagen fibers and secreting diffusible factors that promote epidermal growth (4, 18] .
Psoriasis is a specific human disease that offers a model for studying the regulatory mechanisms involved in a benign hype rprolifera- tion with abnormal d ifferentiation of the epithelium. Recent studies [3] offer evidence that dern1is has a prominent role in the appearance of p soriatic les ions: psoriatic fibrobl as ts induce the hyperproliferation of normal keratinocytes in vitro, suggesting that the primary defect in psoriatic skin may res ide in dermal fibroblasts. Psoriasis thus offers a unique opportunity to study the regulation of growth and differentiation of epidermis by dermis. We previously showed that psoriatic fibroblasts have increased chemotactic and mitoge nic responses to PDGF as compared to normal fibroblasts [5] . The present study confirms these previous results . In addition, as shown in the fibroblasts of four psoriatic patients, this increased effect of PDGF does not seem to be related to an increase in the PDGF receptor number or affinity (Table II) .
PDGF exerts its mitogenic and chemotactic effect via binding to the type-B receptor [ 11] . This receptor is a transmembrane protein w ith an external ligand binding domain and an internal domain w ith protein tyrosine kinase activity that becomes activated after ligand binding [1 9] . Recent studies using PDGF-receptor mutants suggest that the internal part of the PDGF receptor with tyrosine kinase activity has structural domains responsible for specific functions of the receptor [20] . One of these domains seems essential for mitogenesis but not for other cellular responses to POGF such as PDGF-stimu lated increase in intracellular Ca++, PDGF-stimulated conversion of phospho-inositides into inositol phosphates, and PDGF-induced change in intracellular pH. An attractive but still specul ative hypothesis is that psoriasis is a pathologic model in which the internal part of the PDGF receptor is modified in one of these domains, explaining the increased sensitivity of psoriatic fibroblasts to the mitogenic and chemotactic effects of PDGF.
Of interest is the fact that retinoic acid clearly potentiates the mitogenic and c hemotactic effect of PDGF in psoriatic fibroblasts and has only a sli ght and not significant effect in normal fibroblasts . Our data do not reveal a change in the binding kinetics for PDGF in the presence of retinoic acid in psoriatic fibrobl as ts.
These effects of retinoic acid on PDGF action are distinct from its interaction with other growth factors such as EGF or interleukin 2. Retinoic acid enhances the binding of EGF to numerous cell lines [21 ,22] and upregulates the receptors of interleukin 2 on activated human thymocytes [23] .
The results presented in this study suggest that retinoic acid might be acting on the internal domain of PDGF receptor with protein tyrosine kinase activity or on a post-PDGF receptor event such as PDGF-induced protein phosphorylation, hydrolysis of membrane phosphatidylinositol (24] , increase in intracellular calcium [25] , or stimu lation of protein kinase C [26] . One of these effects co uld be involved in the mechanism whereby the mitogenic and chemotactic signal is transmitted from the activated PDGF receptor, and cou ld be the retinoic acid-se nsitive event. This in vitro potentiation of the PDGF bioactivity on psoriatic fibroblasts by retinoic acid is difficult to relate to th e beneficial effect of retinoid therapy in actual knowledge of the disease.
Psoriatic fibroblasts, as well as normal fibroblasts , do not produce PDGF as measured by radioreceptor assay (F. Raynaud, unpublished results). In addition, retinoic acid does not induce a PDGF secretion in psoriatic fibrob lasts (F. Raynaud, unpublished results). These data excl ude the fact that an autocrine system for PDGF controls psoriatic fibrob last growth. However, endothelial cells [27] and activated macrophages [28] produce PDGF, suggesting a paracrine mechanism involved in the stimulation of connective tissue cell mitogenicity and in the inflammatory process in the dermis of psoriatic patients.
